Literature DB >> 10600866

S-T segment voltage during sequential coronary occlusions is an unreliable marker of preconditioning.

M Birincioglu1, X M Yang, S D Critz, M V Cohen, J M Downey.   

Abstract

During coronary angioplasty, a stair-step decrease in peak S-T segment elevation from the first to the second coronary occlusion has been assumed to indicate a preconditioning (PC) effect. This association was evaluated with myocardial electrograms in rabbits, which revealed that two sequential 5-min coronary occlusions resulted in a marked decrease in the area under the S-T segment voltage-time curve (P < 0.05) with no change during a third occlusion. Pretreatment with either 5-hydroxydecanoate, a mitochondrial ATP-sensitive potassium (K(ATP)) channel blocker, or anisomycin, an activator of stress-activated protein kinases, had no effect on the stair-step decline in the S-T segment voltage between the first two occlusions. HMR-1883, a potent closer of sarcolemmal K(ATP) channels, abolished changes in S-T segment elevation after brief coronary occlusions but had no effect on the infarct-sparing property of the two preconditioning 5-min occlusions. Interestingly, HMR-1883 blocked myocardial protection from diazoxide, raising doubt that the latter opens only mitochondrial channels. Therefore, myocardial protection and S-T segment changes during ischemia are dissociated. These data suggest that it is the mitochondrial K(ATP) channel that protects the myocardium, and it is the sarcolemmal channel that is responsible for changes in S-T elevation. Therefore, it cannot always be inferred that changes in S-T segment elevation reflect the state of myocardial protection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10600866     DOI: 10.1152/ajpheart.1999.277.6.H2435

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  4 in total

Review 1.  Efficacy of preconditioning should be gauged by reduction of infarction.

Authors:  Michael V Cohen
Journal:  Br J Pharmacol       Date:  2004-01       Impact factor: 8.739

2.  Antiarrhythmic and anti-ischaemic effects of angina in patients with and without coronary collaterals.

Authors:  R J Edwards; S R Redwood; P D Lambiase; E Tomset; R D Rakhit; M S Marber
Journal:  Heart       Date:  2002-12       Impact factor: 5.994

Review 3.  Multiplicity of effectors of the cardioprotective agent, diazoxide.

Authors:  William A Coetzee
Journal:  Pharmacol Ther       Date:  2013-06-19       Impact factor: 12.310

Review 4.  Evidence for mitochondrial K+ channels and their role in cardioprotection.

Authors:  Brian O'Rourke
Journal:  Circ Res       Date:  2004-03-05       Impact factor: 17.367

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.